Skip to main content

Advertisement

SpringerLink
Log in

Selected physical and chemical properties of commercial Hypericum perforatum extracts relevant for formulated product quality and performance

  • Published:
AAPS PharmSci Aims and scope Submit manuscript

Abstract

Objective. The complex composition-activity relationship of botanicals such as St John's Wort (SJW) presents a major challenge to product development, manufacture, and establishment of appropriate quality and performance standards for the formulated products. As part of a larger study aimed at addressing that challenge, the goals of the present study are to (1) determine and compare the phytochemical profiles of 3 commercial SJW extracts; (2) assess the possible impact of humidity, temperature, and light on their stability; and (3) evaluate several physical properties important to the development of solid dosage forms for these extracts. Methods. An adapted analytical method was developed and validated to determine phytochemical profiles and assess their stability. The extract physical properties measured were particle size (Malvern Mastersizer), flow (Carr's compressibility index; minimum orifice diameter), hygroscopicity (method of Callahan et al), and low-pressure compression physics (method of Heda et al). Results. The phytochemical properties differed greatly among the extracts and were extremely sensitive to changes in storage conditions, with marked instability under conditions of elevated humidity. All extracts exhibited moderate to free-flow properties and were very hygroscopic. Compression properties varied among the extracts and differed from a common use excipient, microcrystalline cellulose. Conclusions. Three commercial sources of SJW extracts exhibited different physical and chemical properties. Standardization to 1 or 2 marker compounds does not ensure chemical equivalence nor necessarily equivalent pharmacological activity. Flow and compression properties appear suitable for automatic capsule-filling machines, but hydroscopicity and the moisture sensitivity of the phytochemical profile are concerns.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Barnes J, Anderson LA, Phillipson D.St. John's Wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties. J Pharm Pharmacol. 2001;53(5):583–600.

    Article  CAS  PubMed  Google Scholar 

  2. Consumer safety symposium on dietary supplements and herbs [press release]. New York: Good Housekeeping Institute; March 3, 1998.

  3. Gurley BJ, Gardner SF, Hubbard MA. Content versus label claims in ephedra-containing dietary supplements. Am J Health Sys Pharm. 2000;57:963–969.

    CAS  Google Scholar 

  4. Cui J, Garle M, Eneroth P, Bjorkhem I. What do commercial ginseng preparations contain? Lancet. 1994;344(8915):134.

    Article  CAS  PubMed  Google Scholar 

  5. Herbal Rx-the promises and the pitfalls. Cons Rep. 1999;May:44–48.

  6. Kopelman SH, Augsburger LL. Some Physical Properties of Ginkgo biloba Extracts Important for Tableting and Encapsulation. JANA 2000;3(2):32–37.

    Google Scholar 

  7. Butterweck V, Jurgenliemk G, Nahrstedt A, Winterhoff H. Flavonoids from Hypericum peforatum show antidepressant activity in the forced swimming test. Planta Med. 2000;66(1):3–6.

    Article  CAS  PubMed  Google Scholar 

  8. Sparenberg B, Demisch L, Holzl J. Investigations of the antidepressive effects of St. John's wort. Pz Wissenschaft. 1993;138(2):50–54.

    Google Scholar 

  9. Calapai G, Crupi A, Firenzuoli F, et al. Effects of Hypericum perforatum on levels of 5-hydroxytryptamine, noradrenaline and dopamine in the cortex, diencephalon and brainstem of the rat. J Pharm Pharmacol. 1999;51(6):723–728.

    Article  CAS  PubMed  Google Scholar 

  10. Calapai G, Crupi A, Firenzuoli F, et al. Serotonin, norepinephrine and dopamine involvement in the antidepressant action of hypericum perforatum. Pharmacopsychiatry. 2001;34(2):45–49.

    Article  CAS  PubMed  Google Scholar 

  11. Sloley BD, Urichuk LJ, Ling L, et al. Chemical and pharmacological evaluation of Hypericum perforatum extracts. Acta Pharmacol. Sin. 2000;21(12):1145–1152.

    CAS  PubMed  Google Scholar 

  12. Chatterjee SS, Noldner M, Koch M, Erdelmeier C. Antidepressant activity of Hypercium perforatum L. and hyperforin, the neglected possibility. Pharmacopsychiatry. 1998;31(1):7–15.

    Article  CAS  PubMed  Google Scholar 

  13. Lavie G, Mazur Y, Lavie D, et al. Hypericin as an inactivator of infectious viruses in blood components. Transfusion. 1995;35(5):392–400.

    Article  CAS  PubMed  Google Scholar 

  14. Chatterjee SS, Bhattacharya SK, Wonnemann M, et al. Hyperforin as a possible antidepressant component of hypericum extracts. Life Sci. 1998;63(6):499–510.

    Article  CAS  PubMed  Google Scholar 

  15. Laakmann G, Schule C, Baghai T, Kieser M. St. John's Wort in mild to moderate depression: The relevance of hyperforin for the clinical efficacy. Pharmacopsychiatry. 1998;31:54–59.

    Article  CAS  PubMed  Google Scholar 

  16. Melzer M, Fuhrken D, Kolkmann R. Hyperforin in St. John's Wort: main active principle or only a key substance? Deut Apoth Zeitung. 1998;138(December):56–62.

    Google Scholar 

  17. INA Methods Validation Program. Hypericum perforatum constituent identification by HPLC. 104.000. Institute for Nutraceutical Advancement. Denver, CO; 2000.

    Google Scholar 

  18. Brolis M, Gabetta B, Fuzzati N, et al. Identification of high-performance liquid chromatography-diode array detection-mass spectrometry and quantification by high performance liquid chromatography-UV absorbance detection of active constituents of Hypericum perforatum. J Chromatogr A. 1998;825:9–16.

    Article  CAS  Google Scholar 

  19. Bilia AR, Bergonzi MC, Morgenni F, et al. Evaluation of chemical stability of St. John's wort commercial extract and some preparations. Int J Pharm. 2001;213:199–208.

    Article  CAS  PubMed  Google Scholar 

  20. INA Methods Validation Program. Determination of hypericin and pseudohypericin in St. John's Wort by high-performance liquid chromatography. 107.000. Institute for Nutraceutical Advancement. Denver, CO;2000:1–4.

    Google Scholar 

  21. INA Methods Validation Program. Determination of hyperforin in St. John's Wort extract and plant material by high-performance liquid chromatography. 112.000. Institute for Nutraceutical Advancement. Denver, CO;2000:1–4.

    Google Scholar 

  22. Maisenbacher P, Kovar KA. Analysis and stability of hyperici oleum. Planta Med. 1992;58(4):351–354.

    Article  CAS  PubMed  Google Scholar 

  23. Orth HCJ, Schmidt PC. Stability and stabilization of hyperforin. Pharm. Ind. 2000;62(1):60–63.

    CAS  Google Scholar 

  24. Fourneron J, Herbette G, Caloprisco E. Pseudohypericin and hypericin in St. John's Wort extracts. Breakdown of pseudohypericin. Comptes Rendes de L'Academie des Sciences Serie II Fascicule G-Chimie. 1999;2(3):127–131.

    CAS  Google Scholar 

  25. Carr RL. Particle behavior, storage, and flow. Brit Chem Eng 1970; 15:1541–1549.

    Google Scholar 

  26. U.S. Pharmacopeial Convention, Inc. Physical tests and determinations-bulk density and tapped density: The United States Pharmacopeia-Pharmacopeial Forum. 24th ed. Rockville, MD: U S Pharmacopeial Convention, Inc.; 1998:6569–6570.

    Google Scholar 

  27. Gioia A. Intrinsic flowability: a new technology for powder flowability classification. Pharm Technol. 1980;February:65–68.

    Google Scholar 

  28. Callahan JC, Cleary GW, Elefant M, et al. Equilibrium moisture content of pharmaceutical excipients. Drug Dev Ind Pharm. 1982;8(3):355–369.

    Article  CAS  Google Scholar 

  29. Heda PK, Muller FX, Augsburger LL. Capsule filling machine simulation. Part 1. Low-force powder compression physics relevant to plug formation. Pharm Dev Tech. 1999;4(2):209–219.

    Article  CAS  Google Scholar 

  30. Shah K. The influence of important mechine operating variables on slug formation, fill weight, and drug release from a dosing disc type automatic capsule filling machine. Ph.D. Dissertation. University of Maryland. Baltimore, MD; 1986.

    Google Scholar 

  31. Nelson E, Naqvi SM, Busse LW, Higuchi T. Physics of tablet compression IV. Relationship of ejection and upper and lower punch forces during the compressional process: application of measurements to comparison of tablet lubricants. J Am Pharm Assoc Sci Ed. 1954;43:596–602.

    Article  CAS  Google Scholar 

  32. Shaxby JH, Evans JC. The variation of presure with depth in columns of powders. Trans Faraday Soc. 1923;19:60–72.

    Article  Google Scholar 

  33. Heckel RW. Density-pressure relationships in powder compression. Trans Metall Soc A I M E 1961;221:671–675.

    CAS  Google Scholar 

  34. Kawakita K, Ludde K.H. Some considerations on powder compression equations. Powder Technol. 1970;4:61–68.

    Article  Google Scholar 

  35. Augsburger LL. Hard and soft shell capsules. In: Banker G, Rhodes CT, eds. Modern Pharmaceutics. New York: Marcel Dekker, Inc; 1995; 441–490.

    Google Scholar 

  36. Kontny MJ, Mulski CA. Gelatin capsule brittleness as a function of relative humidity at room temperature. Int J Pharm. 1989;54:79–85.

    Article  CAS  Google Scholar 

  37. Bell JH, Stevenson NA, Taylor JE. A moisture transfer effect in hard gelatin capsules of sodium cromoglycate. J Pharm Pharmacol. 1973;25(suppl):96P-103P.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Sciences, University of Maryland, 20 North Pine Street, 21201, Baltimore, MD

    Susan H. Kopleman & Larry L. Augsburger

  2. Division of Product Quality Research, Food and Drug Administration, 20891, Kensington, MD

    Agnes NguyenPho

  3. Department of Pharmaceutical Sciences, Saint John's University, 11439, Jamaica, NY

    William S. Zito

  4. Pharmaceutical Development, GlaxoSmithKline, 19406, King of Prussia, PA

    Fran X. Muller

Authors
  1. Susan H. Kopleman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Larry L. Augsburger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Agnes NguyenPho
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. William S. Zito
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fran X. Muller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Larry L. Augsburger.

Additional information

Published: November 14, 2001

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kopleman, S.H., Augsburger, L.L., NguyenPho, A. et al. Selected physical and chemical properties of commercial Hypericum perforatum extracts relevant for formulated product quality and performance. AAPS PharmSci 3, 26 (2001). https://doi.org/10.1208/ps030426

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1208/ps030426

Keywords

Search

Navigation